CDKN2A and posterior cortical atrophy: This drug induces SASP factors and increases the mRNA expression of the senescence markers p16INK4a and p21WAF1/CIP1 in three different prostate epithelial cancer cell lines BPH-1, RWPE-1, and PC3 and prostatectomy samples from PCa patients [32].